Reija Autio

Dr. Reija Autio

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2011 in Nature
Verified
Journal Article
Closed access
SHSamer M. Hussein
Samer M. Hussein
NBNizar N. Batada
Nizar N. Batada
SVSanna Vuoristo
Sanna Vuoristo
RCReagan W. Ching
Reagan W. Ching
RAReija Autio
Reija Autio
TOTimo Otonkoski
Timo Otonkoski

28 March 2010 in Nature Biotechnology
Verified
Journal Article
Closed access
ENElisa Närvä
Elisa Närvä
RAReija Autio
Reija Autio
NRNelly Rahkonen
Nelly Rahkonen
LKLingjia Kong
Lingjia Kong
NHNeil Harrison
Neil Harrison
RLRiitta Lahesmaa
Riitta Lahesmaa

19 September 2008 in Genome Biology
Verified
Journal Article
Open access
SKSami Kilpinen
Sami Kilpinen
RAReija Autio
Reija Autio
KOKalle Ojala
Kalle Ojala
KIKristiina Iljin
Kristiina Iljin
EBElmar Bucher
Elmar Bucher
OKOlli Kallioniemi
Olli Kallioniemi
Our knowledge on tissue- and disease-specific functions of human genes is rather limited and highly context-specific. Here, we have developed a method for the comparison of mRNA expression levels of most human genes across 9,783 Affymetrix gene expression array experiments representing 43 normal human tissue types, 68 cancer types, and 64 other diseases. This database of gene expression patterns in normal human tissues and pathological conditions covers 113 million datapoints and is available from the GeneSapiens website.

22 July 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
STSoile Tuomela
Soile Tuomela
RAReija Autio
Reija Autio
TBTina Buerki-Thurnherr
Tina Buerki-Thurnherr
OAOsman Arslan
Osman Arslan
AKAndrea Kunzmann
Andrea Kunzmann
RLRiitta Lahesmaa
Riitta Lahesmaa
A comprehensive in vitro assessment of two commercial metal oxide nanoparticles, TiO2 and ZnO, was performed using human monocyte-derived macrophages (HMDM), monocyte-derived dendritic cells (MDDC), and Jurkat T cell leukemia-derived cell line. TiO2 nanoparticles were found to be non-toxic whereas ZnO nanoparticles caused dose-dependent cell death. Subsequently, global gene expression profiling was performed to identify transcriptional response underlying the cytotoxicity caused by ZnO nanoparticles. Analysis was done with doses 1 µg/ml and 10 µg/ml after 6 and 24 h of exposure. Interestingly, 2703 genes were significantly differentially expressed in HMDM upon exposure to 10 µg/ml ZnO nanoparticles, while in MDDCs only 12 genes were affected. In Jurkat cells, 980 genes were differentially expressed. It is noteworthy that only the gene expression of metallothioneins was upregulated in all the three cell types and a notable proportion of the genes were regulated in a cell type-specific manner. Gene ontology analysis revealed that the top biological processes disturbed in HMDM and Jurkat cells were regulating cell death and growth. In addition, genes controlling immune system development were affected. Using a panel of modified ZnO nanoparticles, we obtained an additional support that the cellular response to ZnO nanoparticles is largely dependent on particle dissolution and show that the ligand used to modify ZnO nanoparticles modulates Zn2+ leaching. Overall, the study provides an extensive resource of transcriptional markers for mediating ZnO nanoparticle-induced toxicity for further mechanistic studies, and demonstrates the value of assessing nanoparticle responses through a combined transcriptomics and bioinformatics approach.

3 March 2008 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
AJAnna‐Kaarina Järvinen
Anna‐Kaarina Järvinen
RAReija Autio
Reija Autio
SKSami Kilpinen
Sami Kilpinen
MSMatti Saarela
Matti Saarela
ILIlmo Leivo
Ilmo Leivo
OMOuti Monni
Outi Monni

12 December 2011 in Stem Cells
Verified
Journal Article
Open access
PDF file
ENElisa Närvä
Elisa Närvä
NRNelly Rahkonen
Nelly Rahkonen
MEMaheswara Reddy Emani
Maheswara Reddy Emani
Riikka LundRiikka Lund
Riikka Lund
JPJuha‐Pekka Pursiheimo
Juha‐Pekka Pursiheimo
RLRiitta Lahesmaa
Riitta Lahesmaa
Human embryonic stem cells (hESC) have a unique capacity to self-renew and differentiate into all the cell types found in human body. Although the transcriptional regulators of pluripotency are well studied, the role of cytoplasmic regulators is still poorly characterized. Here, we report a new stem cell-specific RNA-binding protein L1TD1 (ECAT11, FLJ10884) required for hESC self-renewal and cancer cell proliferation. Depletion of L1TD1 results in immediate downregulation of OCT4 and NANOG. Furthermore, we demonstrate that OCT4, SOX2, and NANOG all bind to the promoter of L1TD1. Moreover, L1TD1 is highly expressed in seminomas, and depletion of L1TD1 in these cancer cells influences self-renewal and proliferation. We show that L1TD1 colocalizes and interacts with LIN28 via RNA and directly with RNA helicase A (RHA). LIN28 has been reported to regulate translation of OCT4 in complex with RHA. Thus, we hypothesize that L1TD1 is part of the L1TD1-RHA-LIN28 complex that could influence levels of OCT4. Our results strongly suggest that L1TD1 has an important role in the regulation of stemness. STEM CELLS 2012;30:452–460